Dr. Chuang is the Director of Scientific Advisory Services, providing scientific and regulatory expertise covering a variety of drug classes (small to large molecule), therapeutic areas, routes of administration, and animal species. He also manages multidisciplinary research teams for multiple drug development programs from target identification and drug discovery to preclinical safety programs.
Sam has a PhD in microbiology and immunology from the University of Tennessee, Health Science Center, and a Bachelor’s degree in biology from the University of Western Ontario. He is also a member of the American Society of Toxicology.
WEBINAR REPLAY
In Vivo Study Paths Explained: Pros and Cons from CROs to Private Labs
Watch this webinar to gain practical insights to sharpen your preclinical strategy and better use your in vivo resources.